A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus

NCT ID: NCT03969719

Last Updated: 2022-05-11

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

164 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-07-18

Study Completion Date

2021-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a double-blind, placebo-controlled study in adults with non-alcoholic steatohepatitis and Type 2 Diabetes Mellitis on stable dose of metformin monotherapy. Participants will be treated for 16 weeks with placebo or 1 of 2 doses of investigational product to determine the effect on liver fat, HbA1c, safety, tolerability and pharmacodynamics.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-alcoholic Steatohepatitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo

Palacebo

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Placebo

Low Dose

150 mg

Group Type EXPERIMENTAL

PF-06835919

Intervention Type DRUG

150 mg once daily

High Dose

300 mg

Group Type EXPERIMENTAL

PF-06835919

Intervention Type DRUG

300 mg once daily

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Placebo

Placebo

Intervention Type DRUG

PF-06835919

150 mg once daily

Intervention Type DRUG

PF-06835919

300 mg once daily

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Males, or females of nonchildbearing potential
* 18 to 70 years of age
* Type 2 Diabetes Mellitus
* Liver fat \>/=8% by MRI-PDFF
* On stable dose of metformin monotherapy for at least 2 months (at a dose of at least 500 mg daily)

Exclusion Criteria

* History of other liver disease
* Unable to have an MRI performed
* Significant weight loss in the previous month and/or participant in current weight loss program
* History of diabetic complications with end-organ damage
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pfizer

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pfizer CT.gov Call Center

Role: STUDY_DIRECTOR

Pfizer

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Horizon Clinical Research Associates, PLLC

Gilbert, Arizona, United States

Site Status

Clinical Research Consortium an AMR company

Tempe, Arizona, United States

Site Status

Anaheim Clinical Trials LLC-Clinical Research

Anaheim, California, United States

Site Status

Anaheim Clinical Trials, LLC

Anaheim, California, United States

Site Status

Hope Clinical Research

Canoga Park, California, United States

Site Status

San Diego Imaging SDI

Chula Vista, California, United States

Site Status

Sharp Coronado Hospital

Coronado, California, United States

Site Status

Southern California Research Center

Coronado, California, United States

Site Status

Holy Trinity Medical Clinic

Harbor City, California, United States

Site Status

Innovative Clinical Research, Inc.

Harbor City, California, United States

Site Status

ICM Medical Group

Inglewood, California, United States

Site Status

eStudySite

La Mesa, California, United States

Site Status

Clinical Trials Research

Lincoln, California, United States

Site Status

National Research Institute

Los Angeles, California, United States

Site Status

Renaissance Imaging Medical Associates

Northridge, California, United States

Site Status

Huntington Medical Research Institute

Pasadena, California, United States

Site Status

Inland Empire Clinical Trials, LLC

Rialto, California, United States

Site Status

Diagnostic Radiological Imaging Sacramento

Sacramento, California, United States

Site Status

Precision Research Institute

San Diego, California, United States

Site Status

Sharp and Children's MRI Center, LLC

San Diego, California, United States

Site Status

Sharp & Children's MRI Center, LLC

San Diego, California, United States

Site Status

West Coast Radiology

Santa Ana, California, United States

Site Status

Encompass Clinical Research

Spring Valley, California, United States

Site Status

Liberty Pacific Advanced Imaging

Tarzana, California, United States

Site Status

Advanced Gastroenterology

Thousand Oaks, California, United States

Site Status

University Clinical Investigators, Incorporated

Tustin, California, United States

Site Status

Independant Imaging

Atlantis, Florida, United States

Site Status

Twin Lakes Imaging

Daytona Beach, Florida, United States

Site Status

Life Radiology

Doral, Florida, United States

Site Status

MD Clinical LLC

Hallandale, Florida, United States

Site Status

Borland Groover

Jacksonville, Florida, United States

Site Status

Multi-Specialty Research Associates, Inc.

Lake City, Florida, United States

Site Status

Health Care Family Rehab and Research Center

Miami, Florida, United States

Site Status

Clinical Research of Miami

Miami, Florida, United States

Site Status

Finlay Medical Research

Miami, Florida, United States

Site Status

Suncoast Research Group, LLC

Miami, Florida, United States

Site Status

Unique Imaging

Miami, Florida, United States

Site Status

Y & L Advance Health Care, Inc D/B/A Elite Clinical Research

Miami, Florida, United States

Site Status

Stand Up MRI of Miami

Miami, Florida, United States

Site Status

Vital Imaging Center

Miami, Florida, United States

Site Status

Vital Imaging

Miami, Florida, United States

Site Status

Unique Imaging

Miami, Florida, United States

Site Status

International Research Associates

Miami, Florida, United States

Site Status

Panax Clinical Research

Miami Lakes, Florida, United States

Site Status

Advanced Gastroenterology Associates, LLC

Palm Harbor, Florida, United States

Site Status

Rose Radiology

Palm Harbor, Florida, United States

Site Status

Castillo & Torres MD PA

Palm Springs, Florida, United States

Site Status

Ctmd Research Inc

Palm Springs, Florida, United States

Site Status

Progressive Medical Research

Port Orange, Florida, United States

Site Status

Qps-Mra, Llc

South Miami, Florida, United States

Site Status

Physicians Research Associates , LLC

Lawrenceville, Georgia, United States

Site Status

East-West Medical Research Institute

Honolulu, Hawaii, United States

Site Status

Alliance Multispecialty Research, LLC

Wichita, Kansas, United States

Site Status

AA MRC

Flint, Michigan, United States

Site Status

Nebraska Medicine

Omaha, Nebraska, United States

Site Status

University of Nebraska Medical Center

Omaha, Nebraska, United States

Site Status

Excel Clinical Research

Las Vegas, Nevada, United States

Site Status

Alliance for Multispecialty, LLC

Las Vegas, Nevada, United States

Site Status

Desert Radiology

Las Vegas, Nevada, United States

Site Status

Pueblo Imaging

Las Vegas, Nevada, United States

Site Status

Northwell Imaging of Garden City

Garden City, New York, United States

Site Status

Northwell Health - Center for Liver Diseases and Transplantation

Manhasset, New York, United States

Site Status

PMG Research of Wilmington

Wilmington, North Carolina, United States

Site Status

Gastroenterology Associates of the Piedmont, PA

Winston-Salem, North Carolina, United States

Site Status

PMG Research of Winston Salem

Winston-Salem, North Carolina, United States

Site Status

CTI Clinical Research Center

Cincinnati, Ohio, United States

Site Status

ProScan

Cincinnati, Ohio, United States

Site Status

RAS Health

Marion, Ohio, United States

Site Status

Dallas Diabetes and Endocrine Research Center

Dallas, Texas, United States

Site Status

Southwest Diagnostics Imaging Center

Dallas, Texas, United States

Site Status

PrimeCare Medical Group

Houston, Texas, United States

Site Status

Endocrine IPS, PLLC

Houston, Texas, United States

Site Status

The Endocrine Center

Houston, Texas, United States

Site Status

Texas Center for Drug Development

Houston, Texas, United States

Site Status

Houston Medical Imaging

Houston, Texas, United States

Site Status

South Texas Radiology Imaging Centers

Live Oak, Texas, United States

Site Status

Clinical Trials of Texas

San Antonio, Texas, United States

Site Status

STRIC Northeast Imaging Center

San Antonio, Texas, United States

Site Status

Northeast Clinical Research of San Antonio, LLC (NECRSA, LLC)

Schertz, Texas, United States

Site Status

Clinical Research Partners, LLC

Richmond, Virginia, United States

Site Status

Virginia Endoscopy Group

Richmond, Virginia, United States

Site Status

VCU Gateway Building Basement

Richmond, Virginia, United States

Site Status

Salem VA Medical Center

Salem, Virginia, United States

Site Status

Harborview Medical Center Investigational Drug Services

Seattle, Washington, United States

Site Status

Harborview Medical Center

Seattle, Washington, United States

Site Status

University of Washington Medical Center

Seattle, Washington, United States

Site Status

Discovery Clinical Services Ltd.

Victoria, British Columbia, Canada

Site Status

West Coast Medical Imaging

Victoria, British Columbia, Canada

Site Status

Nova Scotia Health Authority QE II Health Sciences Centre

Halifax, Nova Scotia, Canada

Site Status

Nova Scotia Health Authority QE II Health Sciences Centre

Halifax, Nova Scotia, Canada

Site Status

Nova Scotia Health Authority - Queen Elizabeth II Health Sciences Centre

Halifax, Nova Scotia, Canada

Site Status

Aggarwal and Associates Limited

Brampton, Ontario, Canada

Site Status

The Western Centre for Functional and Metabolic Mapping

London, Ontario, Canada

Site Status

Oxford Medical Imaging

Mississauga, Ontario, Canada

Site Status

Bluewater Clinical Research Group, Inc.

Sarnia, Ontario, Canada

Site Status

St. Michael's Hospital

Toronto, Ontario, Canada

Site Status

Toronto Liver Centre

Toronto, Ontario, Canada

Site Status

Resonance Magnetique du Saguenay-Lac-Saint-Jean

Chicoutimi, Quebec, Canada

Site Status

Ecogene-21

Chicoutimi, Quebec, Canada

Site Status

Clinique de Medecine Urbaine du Quartier Latin

Montreal, Quebec, Canada

Site Status

McGill University Health Centre (MUHC)

Montreal, Quebec, Canada

Site Status

MRI TTT Philips Radiation Oncology

Montreal, Quebec, Canada

Site Status

Radiologie Varad

Montreal, Quebec, Canada

Site Status

IRM Quebec

Québec, , Canada

Site Status

Centre de Recherche Saint-Louis

Québec, , Canada

Site Status

ALPHA Recherche Clinique Lebourgneuf

Québec, , Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Canada

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Related Links

Access external resources that provide additional context or updates about the study.

https://pmiform.com/clinical-trial-info-request?StudyID=C1061011

To obtain contact information for a study center near you, click here.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DOSE RESPONSE IN PATIENTS

Identifier Type: OTHER

Identifier Source: secondary_id

C1061011

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.